The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16362 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Aditya K Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: 5-alpha Reductase Inhibitors, Alopecia, Minoxidil. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The evidence base pertaining to the efficacy of monotherapies for androgenetic alopecia (AGA), the most common form of hair loss, is ever expanding—and this warrants a formal comparison therapies' effect on a frequent basis.
Aims
The objective of the current study was to determine the comparative effect of relevant monotherapies for male AGA. Patients/Methods Our aim was achieved by conducting Bayesian network meta‐analysis (NMA), under a random effects model, for two outcomes: 6‐month change in (1) total and (2) terminal hair density in adult (i.e., aged 18 years and above) men with AGA; these analyses were preceded by a systematic search of the peer‐reviewed literature for suitable data. Interventions' surface under the cumulative ranking curve (SUCRA) and pairwise relative effects (quantified as mean differences) were estimated through the NMAs.
Results
We determined the comparative effect of 20 active comparators and a control (i.e., placebo/vehicle). “Dutasteride 0.5 mg once daily for 24 weeks” was ranked the most effective in terms of 6‐month change in (1) total hair density (SUCRA = 87%) and terminal hair density (SUCRA = 98%). Our results showed that interventions’ effectiveness can be dose dependent.
Conclusions
Our updated analyses of the up‐to‐date evidence regarding monotherapies for male AGA showed that the oral form of 5‐alpha reductase inhibitors are more effective than oral minoxidil and other newer agents like Botox, microneedling, and photobiomodulation. Our findings can better inform clinical decision making and design of future research studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada.
- Mediprobe Research Inc., London, Ontario, Canada.
- School of Pharmacy, BRAC University, Dhaka, Bangladesh.
ORCID-Profile: Aditya K Gupta, Mesbah Talukder
Zitieren
APA
Gupta, A. K., Bamimore, M. A., Wang, T., & Talukder, M. (2024). The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16362
Vancouver
Gupta AK, Bamimore MA, Wang T, Talukder M. The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16362
BibTeX
@article{Gupta2024,
author = {Gupta, Aditya K and Bamimore, Mary A and Wang, Tong and Talukder, Mesbah},
title = {The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16362}
}
EUVIMED